| |||||||||||||||
Former Names B6C3Fe-a/a-Col1a2oim/+ (Changed: 15-DEC-04 ) Type Mutant Strain; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Outcross-Intercross (Female x Male) 01-MAR-06 TJL Breeding Summary: homozygote x B6C3Fe a/a F1 or B6C3Fe a/a F1 x homozygote then heterozygote x heterozygote Species laboratory mouse Generation N43F1 (21-DEC-11)
Generation DefinitionsAppearance
black, skeletal defects
Related Genotype: a/a Col1a2oim/Col1a2oim
black, normal outward appearance
Related Genotype: a/a +/? or a/a Col1a2oim/+Development
The mutation to osteogenesis imperfecta (oim) arose spontaneously in 1985 in the F2 generation of a C57BL/6J male bred with a C3H/HeJ-din ovarian transplant host which was itself a B6C3Fe-a/a F1 hybrid. In this F2 generation a pair of mice showing the abnormal leg development were mated and an affected offspring was outcrossed to a B6C3FeF1/J-a/a hybrid. The strain was subsequently maintained by cross-intercross, crossing a homozygote to a B6C3FeF1/J-a/a hybrid to maintain hybrid vigor then intercrossing the heterozygous offspring to produce affected homozygotes for the next cross to the F1 hybrid. In 1991 B6C3FeF1/J-a/a hybrid females were bred with N13 males homozygous for oim to generate embryos for cryopreservation.
| Control | ||
|---|---|---|
| Untyped from the colony | ||
| 001022 B6C3FeF1/J a/a | ||
| Considerations for Choosing Controls | ||
Strains carrying a allele
View Strains carrying a (103 strains)
Strains carrying other alleles of Col1a2
007248 B6.129(FVB)-Col1a2tm1.1Mcbr/J 016237 B6.Cg-Tg(Col1a2-cre/ERT)7Cpd/J View Strains carrying other alleles of Col1a2 (2 strains)
Strains carrying other alleles of a
View Strains carrying other alleles of a (178 strains)
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
Osteogenesis Imperfecta, Type III - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s). View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
Col1a2oim/Col1a2+
B6C3Fe a/a-Col1a2oim/J
- skeleton phenotype
- abnormal compact bone morphology
- cortical bone consists of areas of normal lamellar bone intermixed with hypercellular, highly vascularized bone, however cortical thickness is normal (MGI Ref ID J:38013)
- decreased bone strength
- although heterozygotes do not exhibit fractures, they show reduced bone mechanical strength (MGI Ref ID J:38013)
- male and female femurs have a 21% and 18% reduction in maximum load, respectively (MGI Ref ID J:38013)
- male and female femurs have a 32% and 39% reduction in energy to failure, respectively, compared to wild-type (MGI Ref ID J:38013)
Col1a2oim/Col1a2oim
involves: C3H/HeJ * C57BL/6JLe
- growth/size phenotype
- decreased body size (MGI Ref ID J:4348)
- skeleton phenotype
- abnormal bone mineralization
- mineral crystals within cortical bone are thinner and less well aligned, probably contributing to the brittleness of bones (MGI Ref ID J:31692)
- abnormal caudal vertebrae morphology
- periodically noticeable breaks in the tail vertebrae (MGI Ref ID J:4348)
- abnormal compact bone lamellar structure
- lack of normal lamellar organization of the cortical bone (MGI Ref ID J:4348)
- abnormal joint morphology
- abnormal long bone morphology (MGI Ref ID J:31692)
- exhibit visible breaks in the long bones of the legs (MGI Ref ID J:4348)
- camptomelia
- bowing of the long bones (MGI Ref ID J:4348)
- abnormal osteocyte morphology
- increase in the number or density of cortical osteocytes (MGI Ref ID J:4348)
- decreased bone mineral density
- generalized osteopenia (MGI Ref ID J:4348)
- decreased bone trabecula number
- femurs at 7 months of age show fewer medullary trabeculae (MGI Ref ID J:4348)
- decreased compact bone thickness (MGI Ref ID J:31692)
- femurs at 7 months of age show cortical thinning and an increase in the number or density of cortical osteocytes (MGI Ref ID J:4348)
- decreased tendon stiffness
- tendon collagen is less resistant to tensile stress than wild-type collagen indicating that tendons are weaker (MGI Ref ID J:41509)
- fragile skeleton (MGI Ref ID J:31692)
- homozygotes are born with bone fractures or develop them at an early age and mutants often show evidence of healed fractures (MGI Ref ID J:4348)
- kyphosis
- older mice develop dorsal kyphosis (MGI Ref ID J:4348)
- scoliosis
- in older mice (MGI Ref ID J:4348)
- behavior/neurological phenotype
- abnormal gait
- older animals develop an abnormal gait (MGI Ref ID J:4348)
- cardiovascular system phenotype
- hemorrhage
- hemorrhage into the joint cavities, sides of the body, or around the scapulas (MGI Ref ID J:4348)
- limbs/digits/tail phenotype
- abnormal caudal vertebrae morphology
- periodically noticeable breaks in the tail vertebrae (MGI Ref ID J:4348)
- abnormal forelimb morphology
- drooping wrist appearance due to subluxation on one or both forepaws (MGI Ref ID J:4348)
- abnormal long bone morphology (MGI Ref ID J:31692)
- exhibit visible breaks in the long bones of the legs (MGI Ref ID J:4348)
- camptomelia
- bowing of the long bones (MGI Ref ID J:4348)
- muscle phenotype
- decreased tendon stiffness
- tendon collagen is less resistant to tensile stress than wild-type collagen indicating that tendons are weaker (MGI Ref ID J:41509)
- integument phenotype
- abnormal skin morphology
- fibroblasts in the skin contain greatly dilated cisternae of the rough endoplasmic reticulum (MGI Ref ID J:4348)
- abnormal dermal layer morphology
- dermal fibroblasts exhibit a rounded morphology instead of the typical elongated shape (MGI Ref ID J:4348)
Col1a2oim/Col1a2oim
B6C3Fe a/a-Col1a2oim/J
- skeleton phenotype
- abnormal compact bone morphology
- cortical bone appears disorganized, very cellular, and highly vascularized (MGI Ref ID J:38013)
- abnormal compact bone lamellar structure
- exhibit very little lamellar structure (MGI Ref ID J:38013)
- abnormal tendon morphology
- higher than normal denaturation temperature of the tail tendon (MGI Ref ID J:124000)
- decreased bone strength
- femurs have reduced biomechanical properties in bending (MGI Ref ID J:38013)
- male and female femurs have a 67% and 60% reduction in maximum load, respectively (MGI Ref ID J:38013)
- both male and female femurs have a 79% reduction in energy to failure compared to wild-type (MGI Ref ID J:38013)
- male and female femurs have a 64% and 40% reduction in stiffness, respectively (MGI Ref ID J:38013)
- muscle phenotype
- abnormal tendon morphology
- higher than normal denaturation temperature of the tail tendon (MGI Ref ID J:124000)
- cellular phenotype
- *normal* cellular phenotype
- normal hydroxylation of lysine in skin and tendon (MGI Ref ID J:124000)
- integument phenotype
- abnormal skin morphology
- thermogram assessment shows a 2.3 degree increase in skin denaturation temperature (MGI Ref ID J:124000)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Col1a2oim related
Developmental Biology Research
Defects in Extracellular Matrix Molecules
Skeletal Defects
Mouse/Human Gene Homologs
osteogenesis imperfecta congenita, Ehlers-Danlos syndrome, type VII, autosomal dominant
| Allele Symbol | Col1a2oim | ||
|---|---|---|---|
| Allele Name | osteogenesis imperfecta | ||
| Allele Type | Spontaneous | ||
| Common Name(s) | oim; | ||
| Strain of Origin | (C3H/HeJ x C57BL/6JLe)F2 | ||
| Gene Symbol and Name | Col1a2, collagen, type I, alpha 2 | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | AA960264; AI325291; Col1a-2; Cola-2; Cola2; OI4; expressed sequence AA960264; expressed sequence AI325291; oim; osteogenesis imperfecta; procollagen type I, alpha 2; | ||
| General Note | Heterozygotes exhibit phenotypic similarity to human syndrome: mild form of osteogenesis imperfecta (J:38013). | ||
| Molecular Note | A deletion of a single G residue at position 3983 is predicted to result in a frameshift mutation and an alteration of the last 48 amino acids in the encoded protein. [MGI Ref ID J:17202] [MGI Ref ID J:41994] [MGI Ref ID J:4348] | ||
| Allele Symbol | a | ||
| Allele Name | nonagouti | ||
| Allele Type | Spontaneous | ||
| Strain of Origin | old mutant of the mouse fancy | ||
| Gene Symbol and Name | a, nonagouti | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | AGSW; AGTI; AGTIL; ASP; As; SHEP9; agouti; agouti signal protein; agouti suppressor; | ||
| Molecular Note | Characterization of this allele shows an insertion of DNA comprised of a 5.5kb virus-like element, VL30, into the first intron of the agouti gene. The VL30 element itself contains an additional 5.5 kb sequence, flanked by 526 bp of direct repeats. The host integration site is the same as for at-2Gso and Aw-38J and includes a duplication of four nucleotides of host DNA and a deletion of 2 bp from the end of each repeat. Northern analysis of mRNA from skin of homozygotes shows a smaller agouti message and levels 8 fold lower than found in wild-type. [MGI Ref ID J:16984] [MGI Ref ID J:24934] | ||
Genotyping Protocols
Col1a2oim, Pyrosequencing
Helpful Links
Genotyping resources and troubleshooting
Weis SM; Emery JL; Becker KD; McBride DJ Jr; Omens JH; McCulloch AD. 2000. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circ Res 87(8):663-9. [PubMed: 11029401] [MGI Ref ID J:82592]
Col1a2oim relateda relatedBrodeur AC; Wirth DA; Franklin CL; Reneker LW; Miner JH; Phillips CL. 2007. Type I collagen glomerulopathy: postnatal collagen deposition follows glomerular maturation. Kidney Int 71(10):985-93. [PubMed: 17361118] [MGI Ref ID J:136784]
Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL. 1999. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res 14(2):264-72. [PubMed: 9933481] [MGI Ref ID J:54730]
Camacho NP; Landis WJ; Boskey AL. 1996. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res 35(1-4):259-65. [PubMed: 9084664] [MGI Ref ID J:39178]
Carleton SM; McBride DJ; Carson WL; Huntington CE; Twenter KL; Rolwes KM; Winkelmann CT; Morris JS; Taylor JF; Phillips CL. 2008. Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone 42(4):681-94. [PubMed: 18313376] [MGI Ref ID J:136569]
Carleton SM; Whitford GM; Phillips CL. 2010. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy. J Nutr 140(10):1752-6. [PubMed: 20724489] [MGI Ref ID J:164391]
Chipman SD; Sweet HO; McBride DJ Jr; Davisson MT; Marks SC Jr; Shuldiner AR; Wenstrup RJ; Rowe DW; Shapiro JR. 1993. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A 90(5):1701-5. [PubMed: 8446583] [MGI Ref ID J:4348]
Dong XN; Zoghi M; Ran Q; Wang X. 2010. Collagen mutation causes changes of the microdamage morphology in bone of an OI mouse model. Bone 47(6):1071-5. [PubMed: 20736092] [MGI Ref ID J:166371]
Fratzl P; Paris O; Klaushofer K; Landis WJ. 1996. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest 97(2):396-402. [PubMed: 8567960] [MGI Ref ID J:31692]
Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P. 2001. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone 29(5):453-7. [PubMed: 11704498] [MGI Ref ID J:109416]
Guillot PV; Cook HT; Pusey CD; Fisk NM; Harten S; Moss J; Shore I; Bou-Gharios G. 2008. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 214(5):627-36. [PubMed: 18266309] [MGI Ref ID J:133328]
Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW. 2002. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143(5):1594-601. [PubMed: 11956140] [MGI Ref ID J:76321]
Li F; Wang X; Niyibizi C. 2010. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 47(3):546-55. [PubMed: 20570757] [MGI Ref ID J:165164]
Li H; Jiang X; Delaney J; Franceschetti T; Bilic-Curcic I; Kalinovsky J; Lorenzo JA; Grcevic D; Rowe DW; Kalajzic I. 2010. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 176(5):2405-13. [PubMed: 20348238] [MGI Ref ID J:160764]
Lopez Franco GE; Huang A; Pleshko Camacho N; Blank RD. 2005. Dental phenotype of the col1a2(oim) mutation: DI is present in both homozygotes and heterozygotes. Bone 36(6):1039-46. [PubMed: 15878701] [MGI Ref ID J:105006]
McBride DJ Jr; Choe V; Shapiro JR; Brodsky B. 1997. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol 270(2):275-84. [PubMed: 9236128] [MGI Ref ID J:41994]
McBride DJ Jr; Shapiro JR. 1994. Confirmation of a G nucleotide deletion in the Cola-2 gene of mice with the osteogenesis imperfecta mutation. Genomics 20(1):135-7. [PubMed: 8020944] [MGI Ref ID J:17202]
McBride DJ Jr; Shapiro JR; Dunn MG. 1998. Bone geometry and strength measurements in aging mice with the oim mutation. Calcif Tissue Int 62(2):172-6. [PubMed: 9437052] [MGI Ref ID J:45596]
Mehrotra M; Rosol M; Ogawa M; Larue AC. 2010. Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies. Exp Hematol 38(7):593-602. [PubMed: 20417683] [MGI Ref ID J:164084]
Miles CA; Sims TJ; Camacho NP; Bailey AJ. 2002. The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol 321(5):797-805. [PubMed: 12206762] [MGI Ref ID J:124000]
Misof K; Landis WJ; Klaushofer K; Fratzl P. 1997. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest 100(1):40-5. [PubMed: 9202055] [MGI Ref ID J:41509]
Pfeiffer BJ; Franklin CL; Hsieh FH; Bank RA; Phillips CL. 2005. Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. Matrix Biol 24(7):451-8. [PubMed: 16095890] [MGI Ref ID J:102262]
Phillips CL; Bradley DA; Schlotzhauer CL; Bergfeld M; Libreros-Minotta C; Gawenis LR; Morris JS; Clarke LL; Hillman LS. 2000. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 27(2):219-26. [PubMed: 10913914] [MGI Ref ID J:82589]
Phillips CL; Pfeiffer BJ; Luger AM; Franklin CL. 2002. Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int 62(2):383-91. [PubMed: 12109999] [MGI Ref ID J:103946]
Roberts-Pilgrim AM; Makareeva E; Myles MH; Besch-Williford CL; Brodeur AC; Walker AL; Leikin S; Franklin CL; Phillips CL. 2011. Deficient degradation of homotrimeric type I collagen, alpha1(I)3 glomerulopathy in oim mice. Mol Genet Metab 104(3):373-82. [PubMed: 21855382] [MGI Ref ID J:178244]
Saban J; Zussman MA; Havey R; Patwardhan AG; Schneider GB; King D. 1996. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone 19(6):575-9. [PubMed: 8968022] [MGI Ref ID J:38013]
Sims TJ; Miles CA; Bailey AJ; Camacho NP. 2003. Properties of collagen in OIM mouse tissues. Connect Tissue Res 44 Suppl 1:202-5. [PubMed: 12952198] [MGI Ref ID J:103112]
Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ. 2011. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117(3):1053-60. [PubMed: 21088133] [MGI Ref ID J:168596]
Weis SM; Emery JL; Becker KD; McBride DJ Jr; Omens JH; McCulloch AD. 2000. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circ Res 87(8):663-9. [PubMed: 11029401] [MGI Ref ID J:82592]
Baba K; Sakakibara S; Setsu T; Terashima T. 2007. The superficial layers of the superior colliculus are cytoarchitectually and myeloarchitectually disorganized in the reelin-deficient mouse, reeler. Brain Res 1140:205-15. [PubMed: 17173877] [MGI Ref ID J:120267]
Batchelor AL; Phillips RJ; Searle AG. 1966. A comparison of the mutagenic effectiveness of chronic neutron- and gamma-irradiation of mouse spermatogonia. Mutat Res 3(3):218-29. [PubMed: 5962396] [MGI Ref ID J:5021]
Bjorbaek C; Elmquist JK; Frantz JD; Shoelson SE; Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1(4):619-25. [PubMed: 9660946] [MGI Ref ID J:119803]
Bultman SJ; Klebig ML; Michaud EJ; Sweet HO; Davisson MT; Woychik RP. 1994. Molecular analysis of reverse mutations from nonagouti (a) to black-and-tan (a(t)) and white-bellied agouti (Aw) reveals alternative forms of agouti transcripts. Genes Dev 8(4):481-90. [PubMed: 8125260] [MGI Ref ID J:16984]
Bultman SJ; Michaud EJ; Woychik RP. 1992. Molecular characterization of the mouse agouti locus. Cell 71(7):1195-204. [PubMed: 1473152] [MGI Ref ID J:3523]
Bultman SJ; Russell LB; Gutierrez-Espeleta GA; Woychik RP. 1991. Molecular characterization of a region of DNA associated with mutations at the agouti locus in the mouse. Proc Natl Acad Sci U S A 88(18):8062-6. [PubMed: 1896452] [MGI Ref ID J:16567]
Bundschuh VG; Madry M. 1988. [atwp mutation in an albino mouse substrain (AB/Hum-1)] Z Versuchstierkd 31(6):249-54. [PubMed: 3227730] [MGI Ref ID J:16568]
Butler AE; Janson J; Soeller WC; Butler PC. 2003. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52(9):2304-14. [PubMed: 12941770] [MGI Ref ID J:132530]
Cattanach BM. 1961. A chemically-induced variegated-type position effect in the mouse. Z Vererbungsl 92:165-82. [PubMed: 13877379] [MGI Ref ID J:160128]
Cropley JE; Suter CM; Beckman KB; Martin DI. 2006. Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci U S A 103(46):17308-12. [PubMed: 17101998] [MGI Ref ID J:117156]
De Souza J; Butler AA; Cone RD. 2000. Disproportionate inhibition of feeding in A(y) mice by certain stressors: a cautionary note. Neuroendocrinology 72(2):126-32. [PubMed: 10971147] [MGI Ref ID J:102986]
Dickie MM. 1969. Mutations at the agouti locus in the mouse. J Hered 60(1):20-5. [PubMed: 5798139] [MGI Ref ID J:30922]
Duchesnes CE; Naggert JK; Tatnell MA; Beckman N; Marnane RN; Rodrigues JA; Halim A; Pontre B; Stewart AW; Wolff GL; Elliott R; Mountjoy KG. 2009. New Zealand Ginger Mouse: Novel model that associates the tyrp1b pigmentation gene locus with regulation of lean body mass. Physiol Genomics 37(3):164-74. [PubMed: 19293329] [MGI Ref ID J:146052]
Dunn LC. 1928. A Fifth Allelomorph in the Agouti Series of the House Mouse. Proc Natl Acad Sci U S A 14(10):816-9. [PubMed: 16587414] [MGI Ref ID J:15011]
Dunn LC; Macdowell EC; Lebedeff GA. 1937. Studies on Spotting Patterns III. Interaction between Genes Affecting White Spotting and Those Affecting Color in the House Mouse. Genetics 22(2):307-18. [PubMed: 17246842] [MGI Ref ID J:12954]
Enshell-Seijffers D; Lindon C; Morgan BA. 2008. The serine protease Corin is a novel modifier of the Agouti pathway. Development 135(2):217-25. [PubMed: 18057101] [MGI Ref ID J:130426]
Feuerer M; Herrero L; Cipolletta D; Naaz A; Wong J; Nayer A; Lee J; Goldfine AB; Benoist C; Shoelson S; Mathis D. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930-9. [PubMed: 19633656] [MGI Ref ID J:152186]
Fujimoto W; Shiuchi T; Miki T; Minokoshi Y; Takahashi Y; Takeuchi A; Kimura K; Saito M; Iwanaga T; Seino S. 2007. Dmbx1 is essential in agouti-related protein action. Proc Natl Acad Sci U S A 104(39):15514-9. [PubMed: 17873059] [MGI Ref ID J:125193]
Gajewska M; Krysiak E; Wirth-Dziecialowska E. 2010. New coat color mutation mapped in distal part MMU10 MGI Direct Data Submission :. [MGI Ref ID J:162146]
Galbraith DB; Arceci RJ. 1974. Melanocyte populations of yellow and black hair bulbs in the mouse. J Hered 65(6):381-2. [PubMed: 4448905] [MGI Ref ID J:5512]
Galbraith DB; Patrignani AM. 1976. Sulfhydryl compounds in melanocytes of yellow (Ay/a), nonagouti (a/a), and agouti (A/A) mice. Genetics 84(3):587-91. [PubMed: 1001879] [MGI Ref ID J:5737]
Galbraith DB; Wolff GL; Brewer NL. 1980. Hair pigment patterns in different integumental environments of the mouse. Influence of the agouti suppressor (A<s>) mutation on expression of agouti locus alleles. J Hered 71:229-234. [MGI Ref ID J:12033]
Galbraith DB; Wolff GL; Brewer NL. 1979. Tissue microenvironment and the genetic control of hair pigment patterns in mice Dev Genet 1(2):167-179. [MGI Ref ID J:156092]
Geschwind II; Huseby RA; Nishioka R. 1972. The effect of melanocyte-stimulating hormone on coat color in the mouse. Recent Prog Horm Res 28:91-130. [PubMed: 4631622] [MGI Ref ID J:5324]
Granholm DE; Reese RN; Granholm NH. 1996. Agouti alleles alter cysteine and glutathione concentrations in hair follicles and serum of mice (A y/a, A wJ/A wJ, and a/a). J Invest Dermatol 106(3):559-63. [PubMed: 8648194] [MGI Ref ID J:32132]
Gruneberg H. 1952. . In: The Genetics of the Mouse. Martinus Nijhoff, The Hague. [MGI Ref ID J:30758]
Heaney JD; Michelson MV; Youngren KK; Lam MY; Nadeau JH. 2009. Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice. Hum Mol Genet 18(8):1395-404. [PubMed: 19168544] [MGI Ref ID J:146879]
Hearing VJ; Phillips P; Lutzner MA. 1973. The fine structure of melanogenesis in coat color mutants of the mouse. J Ultrastruct Res 43(1):88-106. [PubMed: 4634048] [MGI Ref ID J:5346]
Hustad CM; Perry WL; Siracusa LD; Rasberry C; Cobb L; Cattanach BM; Kovatch R; Copeland NG; Jenkins NA. 1995. Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics 140(1):255-65. [PubMed: 7635290] [MGI Ref ID J:24934]
Iwatsuka H; Shino A; Suzuoki Z. 1970. General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17(1):23-35. [PubMed: 5468422] [MGI Ref ID J:26460]
Jackson IJ; Budd PS; Keighren M; McKie L. 2007. Humanized MC1R transgenic mice reveal human specific receptor function. Hum Mol Genet 16(19):2341-8. [PubMed: 17652101] [MGI Ref ID J:129904]
Kaminen-Ahola N; Ahola A; Maga M; Mallitt KA; Fahey P; Cox TC; Whitelaw E; Chong S. 2010. Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genet 6(1):e1000811. [PubMed: 20084100] [MGI Ref ID J:156866]
Kappenman KE; Dvoracek MA; Harvison GA; Fuller BB; Granholm NH. 1992. Tyrosinase abundance and activity in murine hairbulb melanocytes of agouti mutants (C57BL/6J-a/a, Ay/a, and AwJ/AwJ). Pigment Cell Res Suppl 2:79-83. [PubMed: 1409442] [MGI Ref ID J:1295]
Knisely AS; Gasser DL; Silvers WK. 1975. Expression in organ culture of agouti locus genes of the mouse. Genetics 79(3):471-5. [PubMed: 1126628] [MGI Ref ID J:5533]
Lamoreux ML; Wakamatsu K; Ito S. 2001. Interaction of major coat color gene functions in mice as studied by chemical analysis of eumelanin and pheomelanin. Pigment Cell Res 14(1):23-31. [PubMed: 11277491] [MGI Ref ID J:103803]
Lane PW. 1989. Mottled agouti-J (am-J) Mouse News Lett 84:89. [MGI Ref ID J:16570]
Leamy LJ; Hrubant HE. 1971. Effects of alleles at the agouti locus on odontometric traits in the C57BL-6 strain of house mice. Genetics 67(1):87-96. [PubMed: 5556294] [MGI Ref ID J:16571]
Loosli R. 1963. Tanoid--a new agouti mutant in the mouse. J Hered 54:26-29. [MGI Ref ID J:13082]
Markert CL; Silvers WK. 1956. The Effects of Genotype and Cell Environment on Melanoblast Differentiation in the House Mouse. Genetics 41(3):429-50. [PubMed: 17247639] [MGI Ref ID J:12970]
Martin NM; Houston PA; Patterson M; Sajedi A; Carmignac DF; Ghatei MA; Bloom SR; Small CJ. 2006. Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes (Lond) 30(3):430-8. [PubMed: 16172617] [MGI Ref ID J:151302]
Martinez HG; Quinones MP; Jimenez F; Estrada CA; Clark K; Muscogiuri G; Sorice G; Musi N; Reddick RL; Ahuja SS. 2011. Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome. Diabetologia 54(10):2660-8. [PubMed: 21779871] [MGI Ref ID J:177084]
Mayer TC; Fishbane JL. 1972. Mesoderm-ectoderm interaction in the production of the agouti pigmentation pattern in mice. Genetics 71(2):297-303. [PubMed: 4558326] [MGI Ref ID J:5288]
Miller MW; Duhl DM; Vrieling H; Cordes SP; Ollmann MM; Winkes BM; Barsh GS. 1993. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 7(3):454-67. [PubMed: 8449404] [MGI Ref ID J:4186]
Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM. 2009. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun 380(4):818-22. [PubMed: 19338759] [MGI Ref ID J:147343]
Monroe DG; Wipf LP; Diggins MR; Matthees DP; Granholm NH. 1998. Agouti-related maturation and tissue distribution of alpha-Melanocyte Stimulating Hormone in wild-type (AwJ/AwJ) and mutant (Ay/a,a/a) mice. Pigment Cell Res 11(5):310-3. [PubMed: 9877102] [MGI Ref ID J:52183]
Moyer FH. 1966. Genetic variations in the fine structure and ontogeny of mouse melanin granules. Am Zool 6(1):43-66. [PubMed: 5902512] [MGI Ref ID J:5001]
Nuotio-Antar AM; Hachey DL; Hasty AH. 2007. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293(6):E1517-28. [PubMed: 17878220] [MGI Ref ID J:145108]
Pettitt SJ; Liang Q; Rairdan XY; Moran JL; Prosser HM; Beier DR; Lloyd KC; Bradley A; Skarnes WC. 2009. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods :. [PubMed: 19525957] [MGI Ref ID J:149352]
Poole TW. 1975. Dermal-epidermal interactions and the action of alleles at the agouti locus in the mouse. Dev Biol 42(2):203-10. [PubMed: 1090472] [MGI Ref ID J:5519]
Poole TW. 1982. The agouti suppressor (As) coat color mutation in mice: developmental effects on the expression of agouti locus alleles. J Exp Zool 220(1):57-64. [PubMed: 7077265] [MGI Ref ID J:6763]
Quevedo WC Jr.; Chase HB. 1958. An analysis of the light mutation of coat color in mice. J Morphol 102:329-345. [MGI Ref ID J:13094]
Quevedo WC Jr; Holstein TJ. 1992. The shift from physiological genetics to molecular genetics in the study of mouse tyrosinase. Pigment Cell Res Suppl 2:57-60. [PubMed: 1409439] [MGI Ref ID J:3852]
RUSSELL ES. 1949. A quantitative histological study of the pigment found in the coat-color mutants of the house mouse; interdependence among the variable granule attributes. Genetics 34(2):133-45. [PubMed: 18117146] [MGI Ref ID J:148461]
Rakyan VK; Chong S; Champ ME; Cuthbert PC; Morgan HD; Luu KV; Whitelaw E. 2003. Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci U S A 100(5):2538-43. [PubMed: 12601169] [MGI Ref ID J:82396]
Russell ES. 1948. A Quantitative Histological Study of the Pigment Found in the Coat Color Mutants of the House Mouse. II. Estimates of the Total Volume of Pigment. Genetics 33(3):228-36. [PubMed: 17247280] [MGI Ref ID J:148462]
Russell ES. 1946. A Quantitative Histological Study of the Pigment Found in the Coat-Color Mutants of the House Mouse. I. Variable Attributes of the Pigment Granules. Genetics 31(3):327-46. [PubMed: 17247200] [MGI Ref ID J:148463]
Russell ES. 1949. A Quantitative Histological Study of the Pigment Found in the Coat-Color Mutants of the House Mouse. IV. the Nature of the Effects of Genic Substitution in Five Major Allelic Series. Genetics 34(2):146-66. [PubMed: 17247308] [MGI Ref ID J:12958]
Russell LB. 1964. Genetic and Functional Mosaicism in the Mouse. In: The Role of the Chromosomes in Development. Academic Press, New York. [MGI Ref ID J:29504]
Russell LB; Cupp McDaniel MN; Woodiel FN,. 1963. Crossing over within the a "locus" of the mouse Genetics 48:907 Abstr. [MGI Ref ID J:174047]
SILVERS WK. 1958. An experimental approach to action of genes at the agouti locus in the mouse. III. Transplants of newborn Aw-, A-and at-skin to Ay-, Aw-, A-and aa hosts. J Exp Zool 137(1):189-96. [PubMed: 13563791] [MGI Ref ID J:13013]
Sakurai T; Ochiai H; Takeuchi T. 1975. Ultrastructural change of melanosomes associated with agouti pattern formation in mouse hair. Dev Biol 47(2):466-71. [PubMed: 1204945] [MGI Ref ID J:5606]
Silvers WK. 1979. The Coat Colors of Mice; A Model for Mammalian Gene Action and Interaction. In: The Coat Colors of Mice. Springer-Verlag, New York. [MGI Ref ID J:78801]
Soeller WC; Janson J; Hart SE; Parker JC; Carty MD; Stevenson RW; Kreutter DK; Butler PC. 1998. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 47(5):743-50. [PubMed: 9588445] [MGI Ref ID J:133694]
Suto J. 2008. Coincidence of loci for glucosuria and obesity in type 2 diabetes-prone KK-Ay mice. Med Sci Monit 14(2):CR65-74. [PubMed: 18227763] [MGI Ref ID J:131439]
Suto J. 2009. Identification of multiple quantitative trait loci affecting the size and shape of the mandible in mice. Mamm Genome 20(1):1-13. [PubMed: 19067046] [MGI Ref ID J:143893]
Suto J; Matsuura S; Imamura K; Yamanaka H; Sekikawa K. 1998. Genetics of obesity in KK mouse and effects of A(y) allele on quantitative regulation. Mamm Genome 9(7):506-10. [PubMed: 9657845] [MGI Ref ID J:48704]
Suwa A; Yoshino M; Yamazaki C; Naitou M; Fujikawa R; Matsumoto S; Kurama T; Shimokawa T; Aramori I. 2010. RMI1 deficiency in mice protects from diet and genetic-induced obesity. FEBS J 277(3):677-86. [PubMed: 20050919] [MGI Ref ID J:168271]
Tamate HB; Takeuchi T. 1981. Induction of the shift in melanin synthesis in lethal yellow (A<y>/a) mice in vitro. Dev Genet 2:349-356. [MGI Ref ID J:11956]
Tanaka S; Kuwahara S; Nishijima K; Ohno T; Matsuzawa A. 2006. Genetic association of mutation at agouti locus with adrenal x zone morphology in BALB/c mice. Exp Anim 55(4):343-7. [PubMed: 16880681] [MGI Ref ID J:111619]
Tanaka S; Nishimura M; Matsuzawa A. 1994. Genetic association between agouti locus and adrenal X zone morphology in SM/J mice. Acta Anat (Basel) 149(3):170-3. [PubMed: 7976166] [MGI Ref ID J:19308]
The Mammalian Genetics Unit at Harwell. 2004. Information obtained from the Mammalian Genetics Unit, Medical Research Council (MRC), Harwell, UK Unpublished :. [MGI Ref ID J:90559]
Tsuruta Y; Yoshimatsu H; Hidaka S; Kondou S; Okamoto K; Sakata T. 2002. Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression. Am J Physiol Endocrinol Metab 282(4):E967-73. [PubMed: 11882520] [MGI Ref ID J:75872]
Vrieling H; Duhl DM; Millar SE; Miller KA; Barsh GS. 1994. Differences in dorsal and ventral pigmentation result from regional expression of the mouse agouti gene. Proc Natl Acad Sci U S A 91(12):5667-71. [PubMed: 8202545] [MGI Ref ID J:18750]
Wolff GL. 1978. Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse. Genetics 88(3):529-39. [PubMed: 640377] [MGI Ref ID J:5964]
Woychik RP; Generoso WM; Russell LB; Cain KT; Cacheiro NL; Bultman SJ; Selby PB; Dickinson ME; Hogan BL; Rutledge JC. 1990. Molecular and genetic characterization of a radiation-induced structural rearrangement in mouse chromosome 2 causing mutations at the limb deformity and agouti loci. Proc Natl Acad Sci U S A 87(7):2588-92. [PubMed: 2320577] [MGI Ref ID J:10399]
Wu Q; Howell MP; Cowley MA; Palmiter RD. 2008. Starvation after AgRP neuron ablation is independent of melanocortin signaling. Proc Natl Acad Sci U S A 105(7):2687-92. [PubMed: 18272480] [MGI Ref ID J:132184]
Animal Health Reports
Room Number FGB29
Colony Maintenance
Breeding & Husbandry These mice may need to wait until 5 weeks of age to be phenotypically classified. Mating System Outcross-Intercross (Female x Male) 01-MAR-06 TJL Breeding Summary: homozygote x B6C3Fe a/a F1 or B6C3Fe a/a F1 x homozygote then heterozygote x heterozygote Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $138.00 Female or Male Heterozygous for Col1a2oim $225.00 Female or Male Homozygous for Col1a2oim
Pairs /Price (US dollars $) Pair Genotype $276.00 Heterozygous for Col1a2oim x Heterozygous for Col1a2oim Standard Supply
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $179.40 Female or Male Heterozygous for Col1a2oim $292.50 Female or Male Homozygous for Col1a2oim
Pairs /Price (US dollars $) Pair Genotype $358.80 Heterozygous for Col1a2oim x Heterozygous for Col1a2oim Standard Supply
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| Untyped from the colony | ||
| 001022 B6C3FeF1/J a/a | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.